Skipper, while I agree with you, Generex / NGIO ne
Post# of 36536
(Total Views: 356)
Posted On: 03/19/2020 4:21:46 PM
Re: skipper1072 #14530
Skipper, while I agree with you, Generex / NGIO needs to be marketing the you know what out of their products on this.
Joe is a marketing guy and above all else, he should know this part all to well and yet, all this time, we have had a few interviews but nothing really like a slap in the face in this is what we have in test kits, etc...
No major news, nothing that really hits the big media out there like you are hearing from other companies.
We have a CEO that has a background in marketing that heads a company that deals in the healthcare industry. He should be all over this, directing his folks to get all of this out to show the world what Generex / NGIO has.
Yeah, they provided a PR this morning. But, they should be doing a heck of a lot more in all the areas. Are there test kits and if so, when will they be ready? How many? What sets Generex / NGIO apart with their kits and how much, etc... They need to get the ball rolling. Get that funding going. See if the SEC can get the S-1 approved faster to get the funding. Where does that stand?
Lots of opened and unanswered questions.
Joe is a marketing guy and above all else, he should know this part all to well and yet, all this time, we have had a few interviews but nothing really like a slap in the face in this is what we have in test kits, etc...
No major news, nothing that really hits the big media out there like you are hearing from other companies.
We have a CEO that has a background in marketing that heads a company that deals in the healthcare industry. He should be all over this, directing his folks to get all of this out to show the world what Generex / NGIO has.
Yeah, they provided a PR this morning. But, they should be doing a heck of a lot more in all the areas. Are there test kits and if so, when will they be ready? How many? What sets Generex / NGIO apart with their kits and how much, etc... They need to get the ball rolling. Get that funding going. See if the SEC can get the S-1 approved faster to get the funding. Where does that stand?
Lots of opened and unanswered questions.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼